Feraheme (ferumoxytol)
- Region
- 🇪🇺 EU
- Active substance
- ferumoxytol
- Company
- Covis Pharma Europe B.V.
- Status
- Application withdrawn
- Therapeutic area
- Anemia, Iron-Deficiency
- Application
- EMEA/H/C/005974
- ATC
- B03AC
- Official record
- www.ema.europa.eu
Indication
Intravenous treatment of iron deficiency anaemia
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇺🇸 Ferabright Approved · Azurity
- 🇪🇺 Rienso Withdrawn · Takeda Pharma A/S
Follow Feraheme
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.